1. Home
  2. DSGN vs FNKO Comparison

DSGN vs FNKO Comparison

Compare DSGN & FNKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DSGN
  • FNKO
  • Stock Information
  • Founded
  • DSGN 2017
  • FNKO 2017
  • Country
  • DSGN United States
  • FNKO United States
  • Employees
  • DSGN N/A
  • FNKO N/A
  • Industry
  • DSGN Biotechnology: Pharmaceutical Preparations
  • FNKO Recreational Games/Products/Toys
  • Sector
  • DSGN Health Care
  • FNKO Consumer Discretionary
  • Exchange
  • DSGN Nasdaq
  • FNKO Nasdaq
  • Market Cap
  • DSGN 208.9M
  • FNKO 170.7M
  • IPO Year
  • DSGN 2021
  • FNKO 2017
  • Fundamental
  • Price
  • DSGN $5.74
  • FNKO $2.94
  • Analyst Decision
  • DSGN
  • FNKO Buy
  • Analyst Count
  • DSGN 0
  • FNKO 4
  • Target Price
  • DSGN N/A
  • FNKO $7.13
  • AVG Volume (30 Days)
  • DSGN 201.9K
  • FNKO 1.0M
  • Earning Date
  • DSGN 11-06-2025
  • FNKO 11-06-2025
  • Dividend Yield
  • DSGN N/A
  • FNKO N/A
  • EPS Growth
  • DSGN N/A
  • FNKO N/A
  • EPS
  • DSGN N/A
  • FNKO N/A
  • Revenue
  • DSGN N/A
  • FNKO $970,702,000.00
  • Revenue This Year
  • DSGN N/A
  • FNKO N/A
  • Revenue Next Year
  • DSGN N/A
  • FNKO $10.57
  • P/E Ratio
  • DSGN N/A
  • FNKO N/A
  • Revenue Growth
  • DSGN N/A
  • FNKO N/A
  • 52 Week Low
  • DSGN $2.60
  • FNKO $2.22
  • 52 Week High
  • DSGN $7.77
  • FNKO $14.65
  • Technical
  • Relative Strength Index (RSI)
  • DSGN 43.44
  • FNKO 40.45
  • Support Level
  • DSGN $6.01
  • FNKO $2.90
  • Resistance Level
  • DSGN $7.21
  • FNKO $3.27
  • Average True Range (ATR)
  • DSGN 0.62
  • FNKO 0.19
  • MACD
  • DSGN -0.12
  • FNKO -0.04
  • Stochastic Oscillator
  • DSGN 3.65
  • FNKO 12.68

About DSGN Design Therapeutics Inc.

Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.

About FNKO Funko Inc.

Funko Inc is an USA based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.

Share on Social Networks: